HCA 10-Q Details Q3 Earnings: $1.579B Net Income, Uncompensated Care Up 24%
HCA sits 35% above its 52-week low of $353.99.
Summary
HCA's Q3 10-Q confirms the $19.849 billion revenue and $7.27 diluted EPS already reported, while showing uncompensated care costs up 24% and nine-month operating cash flow down $1.467 billion.
Key Events · Earnings and Guidance · HCA
-
Q3 Results Confirmed in Full Filing
Revenue $19.849 billion (+3.6%) and diluted EPS $7.27 vs $6.96 a year ago; nine-month revenue $59.188 billion (+5.5%) and diluted EPS $22.05.
-
Uncompensated Care Costs Jump
Estimated cost of total uncompensated care was $1.477 billion in Q3 vs $1.188 billion a year ago, and $4.174 billion for nine months vs $3.359 billion, as uninsured admissions rose 27.2%.
-
Operating Cash Flow Falls $1.467 Billion
Nine-month operating cash flow was $8.810 billion vs $10.277 billion, driven by $1.190 billion more in income taxes paid and $472 million of unfavorable working capital.
-
Debt Rises to $50.493 Billion
Total debt increased from $46.492 billion at December 31, 2025, with commercial paper at $5.727 billion vs $2.207 billion; the CPP was upsized to $8.000 billion in July 2026.
Analysis · HCA · Industrial Applications And Services
The headline numbers were already out on October 27, but the full 10-Q fills in the parts that matter for the thesis. Uncompensated care cost jumped to $1.477 billion in Q3 from $1.188 billion a year ago as uninsured admissions rose 27.2%. Nine-month operating cash flow fell to $8.810 billion from $10.277 billion, largely on $1.190 billion more in income tax payments. Debt also climbed to $50.493 billion from $46.492 billion at year-end, with commercial paper up to $5.727 billion. The company is still buying back stock aggressively — 7.2 million shares in Q3 at an average $410.85 — leaving $4.240 billion of authorization.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HCA was trading at $478.08 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $103.5B. The 52-week trading range was $353.99 to $556.52. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.